Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,560 | 415 | 51.5% |
| Travel and Lodging | $4,067 | 14 | 24.5% |
| Consulting Fee | $2,784 | 1 | 16.8% |
| Honoraria | $1,000 | 2 | 6.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 1.2% |
| Education | $6.97 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $4,644 | 39 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $2,951 | 12 | $0 (2024) |
| Boston Scientific Corporation | $2,680 | 71 | $0 (2024) |
| Abbott Laboratories | $1,084 | 27 | $0 (2024) |
| AltaThera Pharmaceuticals LLC | $1,043 | 5 | $0 (2024) |
| The Spectranetics Corporation | $829.86 | 5 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $821.89 | 93 | $0 (2024) |
| Kestra Medical Technology Services, Inc. | $468.89 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $352.87 | 75 | $0 (2023) |
| Amgen Inc. | $277.51 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $969.24 | 37 | Kestra Medical Technology Services, Inc. ($258.77) |
| 2023 | $1,921 | 46 | Boston Scientific Corporation ($1,371) |
| 2022 | $356.02 | 19 | E.R. Squibb & Sons, L.L.C. ($67.73) |
| 2021 | $3,568 | 33 | SANOFI-AVENTIS U.S. LLC ($2,784) |
| 2020 | $1,432 | 31 | AltaThera Pharmaceuticals LLC ($1,000) |
| 2019 | $3,120 | 63 | Medtronic Vascular, Inc. ($2,307) |
| 2018 | $2,654 | 104 | Medtronic Vascular, Inc. ($1,414) |
| 2017 | $2,597 | 101 | Medtronic Vascular, Inc. ($882.60) |
All Payment Transactions
434 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $15.61 | General |
| Category: Cardiology | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: Cardiovascular | ||||||
| 10/16/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $31.52 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $110.90 | General |
| Category: General - Therapies_CRM | ||||||
| 10/08/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: General - Therapies_CRM | ||||||
| 09/18/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $33.49 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Genetic Disease | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: DIABETES | ||||||
| 08/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Cardiology | ||||||
| 07/23/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $148.67 | General |
| Category: Oncology | ||||||
| 07/03/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $36.10 | General |
| Category: Cardiology | ||||||
| 07/02/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $20.87 | General |
| Category: Cardiology | ||||||
| 06/20/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $9.87 | General |
| Category: LUX-Dx_CRM | ||||||
| 06/06/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Cardiac Rhythm Management | ||||||
| 06/05/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $17.82 | General |
| Category: Cardiology | ||||||
| 05/31/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.22 | General |
| Category: Cardiovascular | ||||||
| 05/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/09/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/25/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $113.96 | General |
| Category: DEVICES | ||||||
| 04/18/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: LUX-Dx_CRM | ||||||
| 04/16/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $29.95 | General |
| Category: Cardiology | ||||||
| 04/08/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $8.37 | General |
| Category: EMBLEM_CRM | ||||||
| 03/26/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 3,560 | 6,432 | $1.4M | $462,724 |
| 2022 | 34 | 3,921 | 7,445 | $1.1M | $384,963 |
| 2021 | 39 | 3,655 | 6,627 | $925,540 | $349,169 |
| 2020 | 37 | 3,859 | 6,171 | $838,458 | $284,366 |
All Medicare Procedures & Services
147 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 481 | 995 | $159,200 | $99,401 | 62.4% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 284 | 290 | $348,000 | $68,289 | 19.6% |
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 11 | 11 | $121,000 | $43,803 | 36.2% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 55 | 55 | $91,190 | $41,948 | 46.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 165 | 338 | $50,700 | $22,199 | 43.8% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 371 | 374 | $130,900 | $19,442 | 14.9% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 189 | 609 | $63,336 | $18,764 | 29.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 113 | 175 | $28,000 | $17,761 | 63.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 91 | 95 | $28,500 | $14,051 | 49.3% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 24 | 24 | $48,000 | $10,627 | 22.1% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 308 | 549 | $54,900 | $10,016 | 18.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 238 | 423 | $33,840 | $9,596 | 28.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 436 | 792 | $59,400 | $9,467 | 15.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 113 | 417 | $23,352 | $8,256 | 35.4% |
| 93268 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | Office | 2023 | 50 | 50 | $45,500 | $7,839 | 17.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 116 | $8,700 | $6,226 | 71.6% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 70 | 134 | $9,380 | $5,758 | 61.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 39 | $8,775 | $5,701 | 65.0% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 79 | 233 | $34,950 | $4,782 | 13.7% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 29 | 52 | $9,100 | $4,443 | 48.8% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 77 | 136 | $17,680 | $3,804 | 21.5% |
| 93282 | Programming of single lead implantable defibrillator system | Office | 2023 | 28 | 52 | $9,100 | $3,601 | 39.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $6,500 | $3,598 | 55.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $5,490 | $3,243 | 59.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 19 | 76 | $6,925 | $3,228 | 46.6% |
About Dr. John Caplan, MD
Dr. John Caplan, MD is a Cardiovascular Disease healthcare provider based in Hamilton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386622769.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Caplan, MD has received a total of $16,617 in payments from pharmaceutical and medical device companies, with $969.24 received in 2024. These payments were reported across 434 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($8,560).
As a Medicare-enrolled provider, Caplan has provided services to 14,995 Medicare beneficiaries, totaling 26,675 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 147 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Hamilton, NJ
- Active Since 01/05/2006
- Last Updated 01/28/2010
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1386622769
Products in Payments
- MULTAQ (Drug) $2,935
- Micra (Device) $1,448
- Sotalol Hydrochloride (Drug) $1,043
- WATCHMAN Access System (Device) $981.53
- BALLOON BRIDGE (Device) $829.86
- XARELTO (Drug) $821.89
- Assure WCD (Device) $468.89
- VIGILANT (Device) $422.59
- ENTRESTO (Drug) $332.16
- Advisa (Device) $287.29
- ELIQUIS (Drug) $200.74
- Veltassa (Drug) $200.00
- Corlanor (Drug) $194.08
- Quadra Assura CRT Defibrillator (Device) $175.11
- GENERAL THERAPIES (Device) $148.94
- Optune (Device) $148.67
- Merlin Connectivity and Remote (Device) $142.98
- Quartet CRT Lead (Device) $142.44
- Allure Quadra RF CRT Pacemaker (Device) $132.04
- VIGILANT X4 CRT-D (Device) $131.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Hamilton
Ronald Ryder, Do, DO
Cardiovascular Disease — Payments: $221,146
Zaw Win Tun, Md, MD
Cardiovascular Disease — Payments: $49,563
Mr. Parthiv Shah, Md, MD
Cardiovascular Disease — Payments: $25,555
Jay Patel, Md, MD
Cardiovascular Disease — Payments: $13,977
Dr. Justin Fox, M.d, M.D
Cardiovascular Disease — Payments: $11,855
Apurva Sharma, M.d, M.D
Cardiovascular Disease — Payments: $9,900